Trial Profile
Safety of apremilast combined with biologic agents in patients with plaque psoriasis and psoriatic arthritis: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions
- 01 Feb 2017 New trial record